BCHE and Parkinson disease: It has little effect on butyrylcholinesterase (BChE) or other classical brain receptors and transporters, but has non-cholinergically-mediated post-transcriptional actions at the level of the 5′-untranslated region of the Alzheimer's and Parkinson's disease proteins, amyloid precursor protein and α-synuclein, to lower their synthesis [25]–[27].